youtube_live
Q4 2026 earnings • released • EPS miss -56.95% • Revenue beat +2.44%
See resultschevron_right
TWST:NASDAQ
Twist Bioscience Corp
$111.60
arrow_downward
-2.29%(-2.62) 1D
$111.60
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 13, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TWST...
Open
$110.50
High
$114.42
Low
$106.80
Mkt. cap
7.40B
Avg. vol.
2.90M
Volume
2.05M
52-wk high
$219.71
52-wk low
$23.30
EPS
-$2.08
Beta
2.25
Shares outstanding
65.83M
No. of employees
979
Open
$110.50
High
$114.42
Low
$106.80
Mkt. cap
7.40B
Avg. vol.
2.90M
Volume
2.05M
52-wk high
$219.71
52-wk low
$23.30
EPS
-$2.08
Beta
2.25
Shares outstanding
65.83M
No. of employees
979
News stories
From web sources and news partners
Investing.com
·
16 hours ago
TD Cowen cuts Twist Bioscience stock price target on execution concerns
GuruFocus
·
16 hours ago
TWST Maintained by Canaccord Genuity -- Price Target Lowered to $150
Investing.com
·
1 day ago
Jefferies cuts Twist Bioscience stock price target on AIDD outlook
Yahoo Finance
·
1 day ago
Twist Bioscience Corporation Q4 2026 Earnings Call Summary
Profile
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
About Twist Bioscience Corp
CEOEmily LeProust
Employees979
Founded2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitetwistbioscience.com